H. Reinel

450 total citations
16 papers, 303 citations indexed

About

H. Reinel is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, H. Reinel has authored 16 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Surgery and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in H. Reinel's work include Colorectal Cancer Surgical Treatments (12 papers), Colorectal and Anal Carcinomas (11 papers) and Colorectal Cancer Treatments and Studies (11 papers). H. Reinel is often cited by papers focused on Colorectal Cancer Surgical Treatments (12 papers), Colorectal and Anal Carcinomas (11 papers) and Colorectal Cancer Treatments and Studies (11 papers). H. Reinel collaborates with scholars based in Germany, Australia and France. H. Reinel's co-authors include Hans‐Joachim Schmoll, Karin Haustermans, Timothy Price, Eric Van Cutsem, Bernard Nordlinger, Jean‐François Daisne, Manfred P. Lutz, Carla Hannig, Niall C. Tebbutt and F. Fauth and has published in prestigious journals such as Journal of Clinical Oncology, The American Journal of Medicine and Annals of Oncology.

In The Last Decade

H. Reinel

16 papers receiving 294 citations

Peers

H. Reinel

ONCOL

SURGE

PRM

EPIDE

Evangelos Xynos Greece

Vipul A. Trivedi United States

Roberto Carando Italy

Wolf‐Ferdinand Wieland Germany

Ibrahim Ethem Gecim Türkiye

Richard Ratelle Canada

Michio Hifumi Japan

Abimbola Ayangbesan United States

Haim Leibovitzh Israel

Ken Yamashita Japan

Evangelos Xynos Greece

H. Reinel

60 ×0.2

ONCOL

104 ×0.5

SURGE

32 ×0.8

PRM

20 ×0.6

EPIDE

10 ×0.3

Citations per year, relative to H. Reinel H. Reinel (= 1×) peers Evangelos Xynos

Countries citing papers authored by H. Reinel

Since Specialization

Citations

This map shows the geographic impact of H. Reinel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Reinel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Reinel more than expected).

Fields of papers citing papers by H. Reinel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Reinel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Reinel. The network helps show where H. Reinel may publish in the future.

Co-authorship network of co-authors of H. Reinel

This figure shows the co-authorship network connecting the top 25 collaborators of H. Reinel. A scholar is included among the top collaborators of H. Reinel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Reinel. H. Reinel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Schmoll, Hans‐Joachim, Alexander Stein, Eric Van Cutsem, et al.. (2020). Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD. Journal of Clinical Oncology. 39(1). 17–29. 59 indexed citations

Schmoll, Hans‐Joachim, Karin Haustermans, Timothy Price, et al.. (2018). PETACC-6: Preop chemoradiation and postop chemotherapy (capecitabine +/- oxaliplatin) in locally advanced rectal cancer: Overall survival after long term follow-up. Annals of Oncology. 29. v107–v107. 3 indexed citations

Schmoll, Hans‐Joachim, Karin Haustermans, Timothy Price, et al.. (2018). Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine +/- oxaliplatin in locally advanced rectal cancer: Final results of PETACC-6.. Journal of Clinical Oncology. 36(15_suppl). 3500–3500. 24 indexed citations

Schmoll, Hans‐Joachim, Alexander Stein, Timothy Price, et al.. (2016). Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: final analyses. Annals of Oncology. 27. vi154–vi154. 10 indexed citations

Schmoll, Hans‐Joachim, Karin Haustermans, Timothy Price, et al.. (2014). Preoperative Chemoradiotherapy and Postoperative Chemotherapy with Capecitabine and Oxaliplatin Vs. Capecitabine Alone in Locally Advanced Rectal Cancer: Disease Free Survival at Interim Analysis. Annals of Oncology. 25. ii111–ii111. 6 indexed citations

Schmoll, Hans‐Joachim, Karin Haustermans, Timothy Price, et al.. (2014). Preoperative Chemoradiotherapy and Postoperative Chemotherapy with Capecitabine +/- Oxaliplatin in Locally Advanced Rectal Cancer: Interim Analysis for Disease-Free Survival of Petacc 6. Annals of Oncology. 25. iv170–iv170. 7 indexed citations

Schmoll, Hans‐Joachim, Karin Haustermans, Timothy Price, et al.. (2014). PG 6.2 Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: disease free survival results at interim analysis. European Journal of Cancer. 50. S6–S6. 14 indexed citations

Schmoll, Hans‐Joachim, Karin Haustermans, Timothy Price, et al.. (2014). Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: Disease-free survival results at interim analysis.. Journal of Clinical Oncology. 32(15_suppl). 3501–3501. 61 indexed citations

Haustermans, Karin, Hans‐Joachim Schmoll, Timothy Price, et al.. (2014). OC-0250: First results of the PETACC-6 randomized phase III trial in locally advanced rectal cancer. Radiotherapy and Oncology. 111. S96–S96. 9 indexed citations

10.

Schmoll, Hans‐Joachim, Karin Haustermans, Timothy Price, et al.. (2013). Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: Response to the local treatment after chemoradiation and surgery as secondary endpoint. European Journal of Cancer. 49. 6 indexed citations

11.

Schmoll, Hans‐Joachim, Karin Haustermans, Timothy Price, et al.. (2013). Preoperative Chemoradiotherapy and Postoperative Chemotherapy with Capecitabine and Oxaliplatin vs. Capecitabine Alone in Locally Advanced Rectal Cancer: Response to the Local Treatment After Chemoradiation and Surgery as Secondary Endpoint. Annals of Oncology. 24. iv120–iv120. 4 indexed citations

12.

Schmoll, Hans‐Joachim, Karin Haustermans, Timothy Price, et al.. (2013). Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: First results of the PETACC-6 randomized phase III trial.. Journal of Clinical Oncology. 31(15_suppl). 3531–3531. 37 indexed citations

13.

Glasmacher, Axel, Oliver A. Cornely, Katjana Orlopp, et al.. (2005). Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients. Journal of Antimicrobial Chemotherapy. 57(1). 127–134. 33 indexed citations

14.

Grauer, Andreas, et al.. (1993). Formation of neutralizing antibodies after treatment with human calcitonin. The American Journal of Medicine. 95(4). 439–442. 11 indexed citations

15.

Grauer, Andreas, H. Reinel, Robert F. Ziegler, & Friedhelm Raue. (1993). Neutralizing Antibodies Against Calcitonin. Hormone and Metabolic Research. 25(9). 486–488. 14 indexed citations

16.

Grauer, Andreas, Friedhelm Raue, H. Reinel, et al.. (1992). A new in vitro bioassay for human calcitonin: validation and comparison to the rat hypocalcemia bioassay. Bone and Mineral. 17(1). 65–74. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact